Skip to main content

Table 4 Showing comparison of metabolic and hormonal profile in diabetic subjects and non-diabetic controls on the basis of presence or absence of ultrasonic suggestion of polycystic ovaries (PCO).

From: Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus

Clinical parameter Diabetic subjects Controls P(ANOVA)
  PCO (n = 64) Non-PCO (n = 41) PCO (n = 22) Non-PCO (n = 38)  
Fasting glucose (mg/dl) 123.8 ± 36.28 115.55 ± 32.0 92.14 ± 12.7 85.71 ± 14.6 0.000
Total cholesterol (mg/dl) 189.4 ± 40.9 199.8 ± 57.0 183.27 ± 37.6 183.87 ± 41.3 0.375
Triglycerides (mg/dl) 194.4 ± 69.9 192.4 ± 67.8 182.27 ± 52.1 187.65 ± 80.2 0.895
HDL cholesterol (mg/dl) 42.0 ± 6.6 43.3 ± 8.8 44.00 ± 11.0 43.99 ± 7.6 0.593
LDL cholesterol (mg/dl) 127.5 ± 55.2 131.1 ± 71.9 97.74 ± 40.7 105.76 ± 40.0 0.033
VLDL cholesterol (mg/dl) 38.8 ± 13.9 38.4 ± 13.5 36.45+10.4 37.53+16.0 0.895
LH (IU/L) 7.51+6.65 3.42 +2.21a 7.93 ± 9.52 2.77 ± 2.17b 0.000
FSH (IU/L) 5.82+2.80 7.23+4.86 5.50 ± 2.3 5.11 ± 2.9 0.039
LH/FSH ratio 1.31 ± 0.78 0.55 ± 0.26a 1.3 ± 0.85 0.5 ± 0.26b 0.000
Testosterone (ng/ml) 37.4 ± 23.0 16.9 ± 7.3a 39.6 ± 13.3 18.8 ± 7.5b 0.000
Androstendione (ng/ml) 2.40 ± 1.9 1.04 ± 0.36a 2.10 ± 0.6 1.21 ± 0.40b 0.000
  1. * Mean ± SD
  2. a: P < 0.05, in the subject group, b: P < 0.05, in control group